Search Videos and More
Fox Chase Cancer Center Fellow Dr. Joseph Van Galen Awarded American Society of Clinical Oncology Young Investigator Award
Joseph Van Galen, MD, MS, Chief Fellow in the Hematology/Oncology Fellowship Program at Fox Chase Cancer CenterMarried People May Have Better Colorectal Cancer Outcomes, Fox Chase Cancer Center Study Shows
Namrata Vijayvergia, MD, Assistant Chief of Gastrointestinal Medical Oncology at Fox Chase Cancer CenterElectronic Health Record Intervention Boosts Fertility Preservation for Young Cancer Patients at Fox Chase Cancer Center
Christopher Cann, MD, Director of the Young Adult Cancer Program and Assistant Professor in the Department of Hematology/Oncology at Fox Chase Cancer CenterLocal Excision Possible for More Rectal Cancer Patients, Fox Chase Cancer Center Study Finds
Results from a study presented by Fox Chase Cancer Center researchers at the Society of Surgical Oncology 2025 Annual Meeting suggest that chemotherapy followed by local excision is a promising treatment option for patients with node-negative low rectal cancer.Fox Chase Cancer Center Study Shows That Examining More Lymph Nodes Was Associated With Improved Outcomes for Patients With Colon Cancer
Removing and testing at least 18 lymph nodes during surgery was associated with more accurate staging and better survival rates for colon cancer patients, according to research presented today at the Society of Surgical Oncology 2025 Annual Meeting. The findings from researchers at Fox Chase Cancer Center challenge the current standard of care for staging colon cancer, which calls for removal and examination of 12 lymph nodes.A tragic death becomes a life force.
“A defining moment in my life was when my father was diagnosed with glioblastoma. At the time, we lived in New York’s Hudson Valley, and no area medical center offered treatment for a serious and complicated diagnosis like his. The only available therapy was in Manhattan, so at age 16, with just a learner’s permit, I drove my dad into the city to fight for his life while I maneuvered the George Washington Bridge as a novice driver,” says James P. Nitzkorski, MD, FACS, FSSO, a former Surgical Oncology Fellow at Fox Chase Cancer Center, and now, a surgical oncologist at Nuvance Health and Program Director for the General Surgery Residency at Vassar Brothers Medical Center, both in Poughkeepsie, NY. His father’s experience pJay Simhan, MD, FACS Named Chair of the Department of Urology at Temple University Hospital and the Lewis Katz School of Medicine at Temple University
Jay Simhan, MD, FACS, has been named Chair of the Department of Urology at Temple University Hospital and the Lewis Katz School of Medicine at Temple University.Preventing Lymphedema Right from the Start:
Using Advanced Microsurgery During Cancer Surgery
The Hoofbeats You Hear May Be a Zebra: Cancer Diagnoses in Ages 18 to 39
At Fox Chase, the Young Adult Cancer Program has been developed as a comprehensive, robust resource to help young adults and their doctors face the challenges of cancer just as someone begins to navigate life’s milestones—finishing school, beginning careers, attaining financial stability, and starting families. It’s a clinical and a psychosocial maelstrom.For Some Rectal Cancer Patients, Prophylactic Chemotherapy Meant a 79% Organ Preservation Result
For patients with cancer in the lower part of the rectum that has not spread to the lymph nodes, chemotherapy administered before localized surgery is an effective method of preserving a patient’s surrounding organs, according to a new study by researchers at Fox Chase Cancer Center.Upending NSCLC Survival Rates with New Care Paradigms
For years, researcher-clinician Hossein Borghaei, DO, MS, Chief, Thoracic Medical Oncology, Fox Chase Cancer Center, has been at the forefront of global exploration into the genetic, proteomics, and cellular landscape of non-small cell lung cancer (NSCLC). These efforts have led to the development of innovative clinical trials and new therapeutic paradigms.Fox Chase Cancer Center and Temple Health Physicians and Scientists Present Research at the American Society of Hematology 2024 Annual Meeting
Fox Chase Cancer Center and Temple Health physicians and scientists participated in the presentation and discussion of eight research projects at the American Society of Hematology (ASH) 2024 Annual Meeting, held this past December in San Diego.